Market News & Trends
3/29/2011
Champions Biotechnology Announces Technology Collaboration With CephalonChampions Biotechnology, Inc. recently announced the signing of a technology collaboration agreement with Cephalon, Inc. in which Champions will…
Champions Biotechnology Announces Technology Collaboration With Cephalon
Champions Biotechnology, Inc. recently announced the signing of a technology collaboration agreement with Cephalon, Inc. in which Champions will conduct low passage Tumorgraft studies on…
Drug Delivery International Seeks to Recruit Scientists
Drug Delivery International (DDi) is on the hunt for a clutch of world-class scientists as it embarks on an aggressive growth drive. And as it…
MethylGene Announces $34.5 Million Financing to Develop Oncology & Antifungal Drugs
MethylGene Inc. recently announced its intention to complete a private placement of $34.5 million. Institutional investors participating in the offering include a fund managed by…
Procter & Gamble & TEVA Form Consumer Healthcare Partnership
The Procter & Gamble Company and Teva Pharmaceutical Industries Ltd. recently announced the signing of a master agreement to create a partnership in consumer healthcare…
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Abbott Laboratories
Seattle Genetics, Inc. recently announced it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million…
Unigene's Oral Peptide Drug Delivery Technology Validated
Unigene Laboratories, Inc., a leader in the design, delivery, manufacture, and development of peptide-based therapeutics, recently announced that the statistically significant top-line results released by…
Elan Announces First European Commission Approval of Injectable Treatment Using NanoCrystal Technology
Elan Drug Technologies (EDT), the leading drug delivery unit of Elan Corporation, plc, recently announced that the first injectable product using EDT's NanoCrystal technology has…
Omthera Raises $33.9 Million to Fund Phase III Development
Omthera Pharmaceuticals, Inc., a privately held emerging specialty pharmaceuticals company, recently announced it has raised $33.9 million in a Series B funding round, led by…
Ricerca Biosciences Announces Strategic Collaboration With Fulcrum
Ricerca Biosciences, an integrated preclinical CRO providing services to the biopharmaceutical industry, recently announced a strategic partnership with Fulcrum Pharma, an Aptiv Solutions company, a…
3/15/2011
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune…
Alliqua Successfully Completes Next Milestone in Transdermal Pain Patch Development
Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, recently announced the successful…
Avantor Completes Acquisition of RFCL Limited
Avantor Performance Materials Holdings S.A. recently announced it has completed its acquisition of RFCL Limited from ICICI Venture Funds Management Company Limited. Avantor, previously known…
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, recently announced results of a multi-center Phase IIa…
3/1/2011
Elan & PPD Announce Global Business Relationship in Drug Development Elan, plc and PPD, Inc. recently announced they have formed a global business collaboration focused…
Elan & PPD Announce Global Business Relationship in Drug Development
Elan, plc and PPD, Inc. recently announced they have formed a global business collaboration focused on the advancement, progression, and execution of Elan's development portfolio.…
Ethypharm Sells its Subsidiary in India
The pharmaceutical company Ethypharm recently announced it has sold all of its operations in India to Athena Pharm. Ethypharm leaves India in order to refocus…
ICIG to Acquire Pharmaceutical Intermediates Business From Genzyme
International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates…
Infinity Initiates Phase II Portion of Pancreatic Cancer Trial
Infinity Pharmaceuticals, Inc. recently announced the initiation of the randomized Phase II portion of the trial of IPI-926 in combination with gemcitabine (also known as…
Quintiles Supports Samsung's Entry Into Biopharmaceutical Market
Samsung Electronics Co., Ltd., the world's largest electronics company, and its affiliated companies (Samsung) recently announced they have entered into a strategic partnership with Quintiles,…
